Multiparameter Flow Cytometry Monitoring of T Cell Responses

Holden T Maecker1

  • 1Institute for Immunity, Transplantation, and Infection, Stanford University School of Medicine, Stanford, CA, USA. maecker@stanford.edu.

Insights

Multiparameter flow cytometry can now analyze detailed T cell responses for HIV vaccine efficacy. This optimized protocol enhances antigen-specific T cell monitoring using advanced flow cytometry techniques.

Area of Science:

  • Immunology
  • Vaccinology
  • Biotechnology

Background:

  • Multiparameter flow cytometry is crucial for evaluating cellular immune responses to pathogens and vaccines.
  • Predicting HIV vaccine efficacy requires understanding T cell responses, but trials have yielded limited success.
  • Advanced flow cytometry allows detailed analysis of T cell phenotypes and functions, potentially correlating with protection.

Purpose of the Study:

  • To present an optimized protocol for monitoring antigen-specific T cells.
  • To address technical challenges and lack of standardization in flow cytometry assays.
  • To facilitate the dissection of detailed T cell phenotypes and functions for vaccine development.

Main Methods:

  • Developed an optimized protocol for antigen-specific T cell monitoring using multiparameter flow cytometry.
  • Included specific variations for analyzing multiple cytokines, cell surface proteins, and functional markers (e.g., CD107, CD154, CD137).
  • Referenced published panels for 8-28 color flow cytometry assays.

Main Results:

  • The protocol enables detailed analysis of T cell responses, including cytokine production and surface marker expression.
  • It provides a standardized approach for assessing immune responses relevant to vaccine efficacy.
  • The method allows for the dissection of complex cellular phenotypes and functions.

Conclusions:

  • The presented optimized flow cytometry protocol enhances the monitoring of antigen-specific T cells.
  • This advancement can aid in predicting HIV vaccine efficacy by dissecting detailed immune responses.
  • Standardization and technical improvements in flow cytometry are vital for successful vaccine development.